XENE FY 2023 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$168M

Operating Income

-$214M

Net Income

-$182M

EPS (Diluted)

$-2.73

Cash Flow

Operating Cash Flow

-$145M

Free Cash Flow

-$151M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$965M

Total Liabilities

$37M

Stockholders' Equity

$928M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$9M	-100.0%
Gross Profit	-$168M	$9M	-1875.6%
Operating Income	-$214M	-$129M	-65.7%
Net Income	-$182M	-$125M	-45.5%